|
1
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fokas E, Weiss C and Rödel C: The role of
radiotherapy in the multimodal management of esophageal cancer. Dig
Dis. 31:30–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sjoquist KM, Burmeister BH, Smithers BM,
Zalcberg JR, Simes RJ, Barbour A and Gebski V: Australasian
Gastro-Intestinal Trials Group: Survival after neoadjuvant
chemotherapy or chemoradiotherapy for resectable oesophageal
carcinoma: An updated meta-analysis. Lancet Oncol. 2:681–692. 2011.
View Article : Google Scholar
|
|
4
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
Mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maier P, Hartmann L, Wenz F and Herskind
C: Cellular pathways in response to ionizing radiation and their
targetability for tumor radiosensitization. Int J Mol Sci. 17(pii):
E1022016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lim LP, Lau NC, Garrett-Engele P, Grimson
A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM:
Microarray analysis shows that some microRNAs downregulate large
numbers of target mRNAs. Nature. 433:769–773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Farazi TA, Spitzer JI, Morozov P and
Tuschl T: miRNAs in human cancer. J Pathol. 223:102–115. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao L, Lu X and Cao Y: MicroRNA and
signal transduction pathways in tumor radiation response. Cell
Signal. 25:1625–1634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu B, Wang X, Hu S, Ying X, Wang P, Zhang
X, Wang J, Wang H and Wang Y: miR-21-mediated radioresistance
occurs via promoting repair of DNA double strand breaks. J Biol
Chem. 292:3531–3540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhattacharya A, Schmitz U, Wolkenhauer O,
Schönherr M, Raatz Y and Kunz M: Regulation of cell cycle
checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene.
32:3175–3183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang S, Pan Y, Zhang R, Xu T, Wu W, Zhang
R, Wang C, Huang H, Calin CA, Yang H and Claret FX: Hsa-miR-24-3p
increases nasopharyngeal carcinoma radiosensitivity by targeting
both the 3′UTR and 5′UTR of Jab1/CSN5. Oncogene. 35:6096–6108.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang P, Zhang J, Zhang L, Zhu Z, Fan J,
Chen L, Zhuang L, Luo J, Chen H, Liu L, et al: MicroRNA 23b
regulates autophagy associated with radioresistance of pancreatic
cancer cells. Gastroenterology. 145:1133–1143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oh JS, Kim JJ, Byun JY and Kim IA:
Lin28-let7 modulates radiosensitivity of human cancer cells with
activation of K-Ras. Int J Radiat Oncol Biol Phys. 76:5–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang W, Zhang T, Jin R, Zhao H, Hu J,
Feng B, Zang L, Zheng M and Wang M: MicroRNA-301a promotes
migration and invasion by targeting TGFBR2 in human colorectal
cancer. J Exp Clin Cancer Res. 33:1132014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia X, Zhang K, Luo G, Cen G, Cao J, Huang
K and Qiu Z: Downregulation of miR-301a-3p sensitizes pancreatic
cancer cells to gemcitabine treatment via PTEN. Am J Transl Res.
9:1886–1895. 2017.PubMed/NCBI
|
|
19
|
Damodaran C, Das TP, Papu John AM, Suman
S, Kolluru V, Morris TJ, Faber EN, Rai SN, Messer JC, Alatassi H,
et al: miR-301a expression: A prognostic marker for prostate
cancer. Urol Oncol. 34:e13–e20. 2016. View Article : Google Scholar
|
|
20
|
Cui L, Li Y, Lv X, Li J, Wang X, Lei Z and
Li X: Expression of microRNA-301a and its functional roles in
malignant melanoma. Cell Physiol Biochem. 40:230–244. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang W, Liu M, Guan Y and Wu Q:
Hypoxia-responsive miR-301a and miR-301b promote radioresistance of
prostate cancer cells via downregulating NDRG2. Med Sci Monit.
22:2126–2132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su H, Jin X, Zhang X, Xue S, Deng X, Shen
L, Fang Y and Xie C: Identification of microRNAs involved in the
radioresistance of esophageal cancer cells. Cell Biol Int.
38:318–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su H, Jin X, Zhang X, Zhao L, Lin B, Li L,
Fei Z, Shen L, Fang Y, Pan H, et al: FH535 increases the
radiosensitivity and reverses epithelial-to-mesenchymal transition
of radioresistant esophageal cancer cell line KYSE-150R. J Transl
Med. 13:1042015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nam RK, Benatar T, Wallis CJ, Amemiya Y,
Yang W, Garbens A, Naeim M, Sherman C, Sugar L and Seth A: MiR-301a
regulates E-cadherin expression and is predictive of prostate
cancer recurrence. Prostate. 76:869–884. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kawano M, Tanaka K, Itonaga I, Iwasaki T
and Tsumura H: MicroRNA-301a promotes cell proliferation via PTEN
targeting in Ewing's sarcoma cells. Int J Oncol. 48:1531–1540.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song JL, Nigam P, Tektas SS and Selva E:
microRNA regulation of Wnt signaling pathways in development and
disease. Cell Signal. 27:1380–1391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S,
Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates
nasopharyngeal carcinoma radioresistance by targeting WNT2B in
vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Marie-Egyptienne DT, Lohse I and Hill RP:
Cancer stem cells, the epithelial to mesenchymal transition (EMT)
and radioresistance: Potential role of hypoxia. Cancer Lett.
341:63–72. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shibue T and Weinberg RA: E MTCS Cs, and
drug resistance: The mechanistic link and clinical implications.
Nat Rev Clin Oncol. 14:611–629. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Martin-Belmonte F and Perez-Moreno M:
Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer.
12:23–38. 2011. View
Article : Google Scholar : PubMed/NCBI
|
